Pharmacokinetics and bioavailability of denaverine hydrochloride in healthy subjects following intravenous, oral and rectal single doses

By Staab A.   Schug B.S.   Larsimont V.   Elze M.   Thummler D.   Mutschler E.   Blume H.  

European Journal of Pharmaceutical Sciences, Vol. 18, Iss. 2, 2003-02 ,pp. : 121-128

Elsevier

Access to resources Recommend Favorite

Linagliptin: A Novel Methylxanthin Based Approved Dipeptidyl Peptidase-4 Inhibitor

By  

Current Drug Targets, Vol. 13, Iss. 7, 2012-06 ,pp. : 970-983

Bentham Science Publishers

Access to resources Recommend Favorite

Linagliptin, a dipeptidyl peptidase-4 inhibitor with a unique pharmacological profile, and efficacy in a broad range of patients with type 2 diabetes

By Forst Thomas   Pfützner Andreas  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. : 101-110

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects

By Hassan-Alin M.   Andersonn T.   Bredberg E.   Röhss K.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 665-670

Springer Publishing Company

Access to resources Recommend Favorite

Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects: A Randomized, Double-Blind, Crossover, Placebo-Controlled, Single-Centre Study

By Peeters Pierre A.M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 867-874

Adis International

Access to resources Recommend Favorite